UNITY Biotechnology unitybiotechnology.com


Public list: Pharma Startups (4733) Healthcare Horizons (27)

UNITY Biotechnology (NASDAQ: UBX), formerly Cenexys, designs therapeutics that prevent, halt, or reverse diseases of aging. The company's medicines are designed to lengthen healthspan, the amount of time people live in good health.

UNITY Biotechnology (NASDAQ: UBX), formerly Cenexys, designs therapeutics that prevent, halt, or reverse diseases of aging. The company's medicines are designed to lengthen healthspan, the amount of time people live in good health.

Company (IPO / Went public)

Phone: 650-416-1192

Fax:

3280 Bayshore Boulevard
Suite 100
Brisbane, 94005
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
UNITY Biotechnology $291.3M May 3, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related UNITY Biotechnology Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 22 investors
There is no Competitors data available for this company. Please select another tab.